ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Virus Filter for Biopharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-14X17292
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Virus Filter for Biopharmaceutical Market Research Report 2024
BUY CHAPTERS

Global Virus Filter for Biopharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-14X17292
Report
November 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Danaher (Pall)
Merck KGaA
Sartorius
Agilitech
Asahi Kasei Bioprocess
Lepure Biotech
Hanbon Sci. & Tech.
Hanbon Sci. & Tech.

Virus Filter for Biopharmaceutical Market

The global Virus Filter for Biopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A virus filter for biopharmaceutical applications is a specialized filtration device designed to remove viruses from biopharmaceutical products such as vaccines, recombinant proteins, and monoclonal antibodies. These filters employ advanced filtration media with precise pore sizes that effectively capture and retain viruses while allowing the passage of desired biomolecules. Virus filters play a critical role in ensuring the safety and purity of biopharmaceutical products by minimizing the risk of viral contamination. They are integral components of bioprocessing systems, typically used in downstream processing steps such as clarification, concentration, and sterile filtration, helping to meet stringent regulatory requirements for product quality and safety in the biopharmaceutical industry.
From a downstream perspective, Biopharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Virus Filter for Biopharmaceutical leading manufacturers including Danaher Pall, Merck KGaA, Sartorius, Agilitech, Asahi Kasei Bioprocess, Lepure Biotech, Hanbon Sci.&Tech., etc., dominate supply; the top five capture approximately % of global revenue, with Danaher Pall leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Virus Filter for Biopharmaceutical market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Virus Filter for Biopharmaceutical Market Report

Report Metric Details
Report Name Virus Filter for Biopharmaceutical Market
Segment by Type
  • Single-Use Systems
  • Others
Segment by Application
  • Biopharmaceutical
  • Plasma Processes
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Danaher Pall, Merck KGaA, Sartorius, Agilitech, Asahi Kasei Bioprocess, Lepure Biotech, Hanbon Sci.&Tech.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Virus Filter for Biopharmaceutical study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Virus Filter for Biopharmaceutical Market report?

Ans: The main players in the Virus Filter for Biopharmaceutical Market are Danaher Pall, Merck KGaA, Sartorius, Agilitech, Asahi Kasei Bioprocess, Lepure Biotech, Hanbon Sci.&Tech.

What are the Application segmentation covered in the Virus Filter for Biopharmaceutical Market report?

Ans: The Applications covered in the Virus Filter for Biopharmaceutical Market report are Biopharmaceutical, Plasma Processes, Others

What are the Type segmentation covered in the Virus Filter for Biopharmaceutical Market report?

Ans: The Types covered in the Virus Filter for Biopharmaceutical Market report are Single-Use Systems, Others

1 Study Coverage
1.1 Introduction to Virus Filter for Biopharmaceutical: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Virus Filter for Biopharmaceutical Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single-Use Systems
1.2.3 Others
1.3 Market Segmentation by Application
1.3.1 Global Virus Filter for Biopharmaceutical Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical
1.3.3 Plasma Processes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Virus Filter for Biopharmaceutical Revenue Estimates and Forecasts 2020-2031
2.2 Global Virus Filter for Biopharmaceutical Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Virus Filter for Biopharmaceutical Sales Estimates and Forecasts 2020-2031
2.4 Global Virus Filter for Biopharmaceutical Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Virus Filter for Biopharmaceutical Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Virus Filter for Biopharmaceutical Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single-Use Systems Market Size by Manufacturers
3.5.2 Others Market Size by Manufacturers
3.6 Global Virus Filter for Biopharmaceutical Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Virus Filter for Biopharmaceutical Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Virus Filter for Biopharmaceutical Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Virus Filter for Biopharmaceutical Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Virus Filter for Biopharmaceutical Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Virus Filter for Biopharmaceutical Sales and Revenue by Type (2020-2031)
6.4 North America Virus Filter for Biopharmaceutical Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Virus Filter for Biopharmaceutical Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Virus Filter for Biopharmaceutical Sales and Revenue by Type (2020-2031)
7.4 Europe Virus Filter for Biopharmaceutical Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Virus Filter for Biopharmaceutical Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Virus Filter for Biopharmaceutical Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Virus Filter for Biopharmaceutical Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Virus Filter for Biopharmaceutical Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Virus Filter for Biopharmaceutical Sales and Revenue by Type (2020-2031)
9.4 Central and South America Virus Filter for Biopharmaceutical Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Virus Filter for Biopharmaceutical Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Virus Filter for Biopharmaceutical Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Virus Filter for Biopharmaceutical Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Virus Filter for Biopharmaceutical Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Danaher Pall
11.1.1 Danaher Pall Corporation Information
11.1.2 Danaher Pall Business Overview
11.1.3 Danaher Pall Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.1.4 Danaher Pall Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Danaher Pall Virus Filter for Biopharmaceutical Sales by Product in 2024
11.1.6 Danaher Pall Virus Filter for Biopharmaceutical Sales by Application in 2024
11.1.7 Danaher Pall Virus Filter for Biopharmaceutical Sales by Geographic Area in 2024
11.1.8 Danaher Pall Virus Filter for Biopharmaceutical SWOT Analysis
11.1.9 Danaher Pall Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Corporation Information
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.2.4 Merck KGaA Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Merck KGaA Virus Filter for Biopharmaceutical Sales by Product in 2024
11.2.6 Merck KGaA Virus Filter for Biopharmaceutical Sales by Application in 2024
11.2.7 Merck KGaA Virus Filter for Biopharmaceutical Sales by Geographic Area in 2024
11.2.8 Merck KGaA Virus Filter for Biopharmaceutical SWOT Analysis
11.2.9 Merck KGaA Recent Developments
11.3 Sartorius
11.3.1 Sartorius Corporation Information
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.3.4 Sartorius Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Sartorius Virus Filter for Biopharmaceutical Sales by Product in 2024
11.3.6 Sartorius Virus Filter for Biopharmaceutical Sales by Application in 2024
11.3.7 Sartorius Virus Filter for Biopharmaceutical Sales by Geographic Area in 2024
11.3.8 Sartorius Virus Filter for Biopharmaceutical SWOT Analysis
11.3.9 Sartorius Recent Developments
11.4 Agilitech
11.4.1 Agilitech Corporation Information
11.4.2 Agilitech Business Overview
11.4.3 Agilitech Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.4.4 Agilitech Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Agilitech Virus Filter for Biopharmaceutical Sales by Product in 2024
11.4.6 Agilitech Virus Filter for Biopharmaceutical Sales by Application in 2024
11.4.7 Agilitech Virus Filter for Biopharmaceutical Sales by Geographic Area in 2024
11.4.8 Agilitech Virus Filter for Biopharmaceutical SWOT Analysis
11.4.9 Agilitech Recent Developments
11.5 Asahi Kasei Bioprocess
11.5.1 Asahi Kasei Bioprocess Corporation Information
11.5.2 Asahi Kasei Bioprocess Business Overview
11.5.3 Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.5.4 Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical Sales by Product in 2024
11.5.6 Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical Sales by Application in 2024
11.5.7 Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical Sales by Geographic Area in 2024
11.5.8 Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical SWOT Analysis
11.5.9 Asahi Kasei Bioprocess Recent Developments
11.6 Lepure Biotech
11.6.1 Lepure Biotech Corporation Information
11.6.2 Lepure Biotech Business Overview
11.6.3 Lepure Biotech Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.6.4 Lepure Biotech Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Lepure Biotech Recent Developments
11.7 Hanbon Sci.&Tech.
11.7.1 Hanbon Sci.&Tech. Corporation Information
11.7.2 Hanbon Sci.&Tech. Business Overview
11.7.3 Hanbon Sci.&Tech. Virus Filter for Biopharmaceutical Product Models, Descriptions and Specifications
11.7.4 Hanbon Sci.&Tech. Virus Filter for Biopharmaceutical Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hanbon Sci.&Tech. Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Virus Filter for Biopharmaceutical Industry Chain
12.2 Virus Filter for Biopharmaceutical Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Virus Filter for Biopharmaceutical Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Virus Filter for Biopharmaceutical Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Virus Filter for Biopharmaceutical Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Virus Filter for Biopharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Danaher (Pall)
Merck KGaA
Sartorius
Agilitech
Asahi Kasei Bioprocess
Lepure Biotech
Hanbon Sci. & Tech.
Hanbon Sci. & Tech.
List of Tables
 Table 1. Global Virus Filter for Biopharmaceutical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Virus Filter for Biopharmaceutical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Virus Filter for Biopharmaceutical Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Virus Filter for Biopharmaceutical Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Virus Filter for Biopharmaceutical Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Virus Filter for Biopharmaceutical Sales by Region (2020-2025) & (Units)
 Table 8. Global Virus Filter for Biopharmaceutical Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Virus Filter for Biopharmaceutical Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Virus Filter for Biopharmaceutical Sales Share by Manufacturers (2020-2025)
 Table 12. Global Virus Filter for Biopharmaceutical Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Virus Filter for Biopharmaceutical Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Virus Filter for Biopharmaceutical by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus Filter for Biopharmaceutical as of 2024)
 Table 16. Global Virus Filter for Biopharmaceutical Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Virus Filter for Biopharmaceutical Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Virus Filter for Biopharmaceutical Manufacturing Base and Headquarters
 Table 19. Global Virus Filter for Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Virus Filter for Biopharmaceutical Sales by Type (2020-2025) & (Units)
 Table 23. Global Virus Filter for Biopharmaceutical Sales by Type (2026-2031) & (Units)
 Table 24. Global Virus Filter for Biopharmaceutical Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Virus Filter for Biopharmaceutical Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Virus Filter for Biopharmaceutical ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Virus Filter for Biopharmaceutical Sales by Application (2020-2025) & (Units)
 Table 29. Global Virus Filter for Biopharmaceutical Sales by Application (2026-2031) & (Units)
 Table 30. Virus Filter for Biopharmaceutical High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Virus Filter for Biopharmaceutical Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Virus Filter for Biopharmaceutical Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Virus Filter for Biopharmaceutical ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Virus Filter for Biopharmaceutical Growth Accelerators and Market Barriers
 Table 37. North America Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Virus Filter for Biopharmaceutical Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Virus Filter for Biopharmaceutical Growth Accelerators and Market Barriers
 Table 40. Europe Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Virus Filter for Biopharmaceutical Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Virus Filter for Biopharmaceutical Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Virus Filter for Biopharmaceutical Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Virus Filter for Biopharmaceutical Investment Opportunities and Key Challenges
 Table 47. Central and South America Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Virus Filter for Biopharmaceutical Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Virus Filter for Biopharmaceutical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Danaher Pall Corporation Information
 Table 51. Danaher Pall Description and Major Businesses
 Table 52. Danaher Pall Product Models, Descriptions and Specifications
 Table 53. Danaher Pall Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Danaher Pall Sales Value Proportion by Product in 2024
 Table 55. Danaher Pall Sales Value Proportion by Application in 2024
 Table 56. Danaher Pall Sales Value Proportion by Geographic Area in 2024
 Table 57. Danaher Pall Virus Filter for Biopharmaceutical SWOT Analysis
 Table 58. Danaher Pall Recent Developments
 Table 59. Merck KGaA Corporation Information
 Table 60. Merck KGaA Description and Major Businesses
 Table 61. Merck KGaA Product Models, Descriptions and Specifications
 Table 62. Merck KGaA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Merck KGaA Sales Value Proportion by Product in 2024
 Table 64. Merck KGaA Sales Value Proportion by Application in 2024
 Table 65. Merck KGaA Sales Value Proportion by Geographic Area in 2024
 Table 66. Merck KGaA Virus Filter for Biopharmaceutical SWOT Analysis
 Table 67. Merck KGaA Recent Developments
 Table 68. Sartorius Corporation Information
 Table 69. Sartorius Description and Major Businesses
 Table 70. Sartorius Product Models, Descriptions and Specifications
 Table 71. Sartorius Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Sartorius Sales Value Proportion by Product in 2024
 Table 73. Sartorius Sales Value Proportion by Application in 2024
 Table 74. Sartorius Sales Value Proportion by Geographic Area in 2024
 Table 75. Sartorius Virus Filter for Biopharmaceutical SWOT Analysis
 Table 76. Sartorius Recent Developments
 Table 77. Agilitech Corporation Information
 Table 78. Agilitech Description and Major Businesses
 Table 79. Agilitech Product Models, Descriptions and Specifications
 Table 80. Agilitech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Agilitech Sales Value Proportion by Product in 2024
 Table 82. Agilitech Sales Value Proportion by Application in 2024
 Table 83. Agilitech Sales Value Proportion by Geographic Area in 2024
 Table 84. Agilitech Virus Filter for Biopharmaceutical SWOT Analysis
 Table 85. Agilitech Recent Developments
 Table 86. Asahi Kasei Bioprocess Corporation Information
 Table 87. Asahi Kasei Bioprocess Description and Major Businesses
 Table 88. Asahi Kasei Bioprocess Product Models, Descriptions and Specifications
 Table 89. Asahi Kasei Bioprocess Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Asahi Kasei Bioprocess Sales Value Proportion by Product in 2024
 Table 91. Asahi Kasei Bioprocess Sales Value Proportion by Application in 2024
 Table 92. Asahi Kasei Bioprocess Sales Value Proportion by Geographic Area in 2024
 Table 93. Asahi Kasei Bioprocess Virus Filter for Biopharmaceutical SWOT Analysis
 Table 94. Asahi Kasei Bioprocess Recent Developments
 Table 95. Lepure Biotech Corporation Information
 Table 96. Lepure Biotech Description and Major Businesses
 Table 97. Lepure Biotech Product Models, Descriptions and Specifications
 Table 98. Lepure Biotech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Lepure Biotech Recent Developments
 Table 100. Hanbon Sci.&Tech. Corporation Information
 Table 101. Hanbon Sci.&Tech. Description and Major Businesses
 Table 102. Hanbon Sci.&Tech. Product Models, Descriptions and Specifications
 Table 103. Hanbon Sci.&Tech. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Hanbon Sci.&Tech. Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Virus Filter for Biopharmaceutical Product Picture
 Figure 2. Global Virus Filter for Biopharmaceutical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single-Use Systems Product Picture
 Figure 4. Others Product Picture
 Figure 5. Global Virus Filter for Biopharmaceutical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Biopharmaceutical
 Figure 7. Plasma Processes
 Figure 8. Others
 Figure 9. Virus Filter for Biopharmaceutical Report Years Considered
 Figure 10. Global Virus Filter for Biopharmaceutical Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Virus Filter for Biopharmaceutical Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Virus Filter for Biopharmaceutical Revenue Market Share by Region (2020-2031)
 Figure 14. Global Virus Filter for Biopharmaceutical Sales (2020-2031) & (Units)
 Figure 15. Global Virus Filter for Biopharmaceutical Sales (CAGR) by Region (2020-2031) (Units)
 Figure 16. Global Virus Filter for Biopharmaceutical Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Virus Filter for Biopharmaceutical Sales Volume Market Share in 2024
 Figure 18. Global Virus Filter for Biopharmaceutical Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Single-Use Systems Revenue Market Share by Manufacturer in 2024
 Figure 21. Others Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Virus Filter for Biopharmaceutical Sales Market Share by Type (2020-2031)
 Figure 23. Global Virus Filter for Biopharmaceutical Revenue Market Share by Type (2020-2031)
 Figure 24. Global Virus Filter for Biopharmaceutical Sales Market Share by Application (2020-2031)
 Figure 25. Global Virus Filter for Biopharmaceutical Revenue Market Share by Application (2020-2031)
 Figure 26. North America Virus Filter for Biopharmaceutical Sales YoY (2020-2031) & (Units)
 Figure 27. North America Virus Filter for Biopharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) in 2024
 Figure 29. North America Virus Filter for Biopharmaceutical Sales Volume (Units) by Type (2020- 2031)
 Figure 30. North America Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Virus Filter for Biopharmaceutical Sales Volume (Units) by Application (2020-2031)
 Figure 32. North America Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Virus Filter for Biopharmaceutical Sales YoY (2020-2031) & (Units)
 Figure 37. Europe Virus Filter for Biopharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Virus Filter for Biopharmaceutical Sales Volume (Units) by Type (2020-2031)
 Figure 40. Europe Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Virus Filter for Biopharmaceutical Sales Volume (Units) by Application (2020-2031)
 Figure 42. Europe Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 44. France Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Virus Filter for Biopharmaceutical Sales YoY (2020-2031) & (Units)
 Figure 49. Asia-Pacific Virus Filter for Biopharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Virus Filter for Biopharmaceutical Sales Volume (Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Virus Filter for Biopharmaceutical Sales Volume (Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 59. India Virus Filter for Biopharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Virus Filter for Biopharmaceutical Sales YoY (2020-2031) & (Units)
 Figure 61. Central and South America Virus Filter for Biopharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Virus Filter for Biopharmaceutical Sales Volume (Units) by Type (2021-2031)
 Figure 64. Central and South America Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Virus Filter for Biopharmaceutical Sales Volume (Units) by Application (2020-2031)
 Figure 66. Central and South America Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Virus Filter for Biopharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Virus Filter for Biopharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Virus Filter for Biopharmaceutical Sales YoY (2020-2031) & (Units)
 Figure 70. Middle East and Africa Virus Filter for Biopharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Virus Filter for Biopharmaceutical Sales Volume (Units) by Type (2021-2031)
 Figure 73. South America Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Virus Filter for Biopharmaceutical Sales Volume (Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Virus Filter for Biopharmaceutical Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Virus Filter for Biopharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Virus Filter for Biopharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Virus Filter for Biopharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Virus Filter for Biopharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 80. Virus Filter for Biopharmaceutical Industry Chain Mapping
 Figure 81. Regional Virus Filter for Biopharmaceutical Manufacturing Base Distribution (%)
 Figure 82. Global Virus Filter for Biopharmaceutical Production Market Share by Region (2020-2031)
 Figure 83. Virus Filter for Biopharmaceutical Production Process
 Figure 84. Regional Virus Filter for Biopharmaceutical Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Virus Filtration System Market Research Report 2024
Global Virus Removal Filter System Market Research Report 2024
Global Virus Removal Filtration Technology Market Research Report 2024
Global Biopharmaceutical Filter Membranes Market Research Report 2024
Global Virus Removal Filtration Membrane Market Research Report 2024
Global Virus Removal Syringe Filters Market Research Report 2025
Global Depth Filter for Biopharmaceutical Market Research Report 2024
Global Biopharmaceutical Filtration Market Research Report 2024
Global Biopharmaceutical Filtration Consumables Market Research Report 2024
Global Precision Medicinal Liquid Filter Market Research Report 2024
Global Viral And Bacterial Filters Market Research Report 2024
Global Membrane Materials for Biopharmaceuticals Market Research Report 2024
Global Bioprocess Depth Flow Filtration Market Research Report 2024
Global Depth Filtration Biologics Manufacturing Market Research Report 2024
Global High end Filter Membrane Products Market Research Report 2024
Global Depth Filtration in Life Sciences Biologics Manufacturing Market Research Report 2025
Global Virus Filtration Solutions Market Research Report 2025
Global Medical Filter Membranes Market Research Report 2024
Global Virus Filtration Market Insights Forecast to 2030
Global Pharmaceutical Filtration Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions